OmniAb
Open
$2.29
Prev. Close
$2.29
High
$2.29
Low
$2.27
Market Snapshot
$328.66M
-6.1
-0.59
$26.74M
89
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 89 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 89 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
Recently from Cashu
OmniAb to Present Innovative Antibody Discovery Technology at March Investor Conferences
OmniAb to Showcase Innovative Antibody Discovery Technology at Upcoming Conferences OmniAb, Inc., based in Emeryville, California, is set to highlight its cutting-edge antibody discovery technology du…
OmniAb Enhances Visibility at Upcoming Investor Conferences to Drive Growth and Collaboration
OmniAb Expands Industry Engagement Through Upcoming Conferences OmniAb, Inc., a leader in advanced discovery research technology, is set to increase its visibility in the pharmaceutical and biotech se…
OmniAb Showcases Breakthroughs in Antibody Engineering at AETC 2024
Innovative Advances in Antibody Engineering: OmniAb's Showcase at AETC 2024 OmniAb, Inc. demonstrates its commitment to revolutionizing therapeutic discovery at the 2024 Antibody Engineering & Therape…